http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014102571-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 |
| filingDate | 2014-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2014102571-A |
| titleOfInvention | VETERINARY ANTIVIRAL PRODUCT |
| abstract | 1. Veterinary antiviral preparation containing piperidinium 2- [5- (furan-2-yl) -4-phenyl-1,2,4-triazol-3-ylthio] acetate as an active substance, characterized in that the preparation further comprises 4-hydroxybenzoic acid esters in a weight ratio of 1: (0.03-0.05) .2. The veterinary antiviral preparation according to claim 1, characterized in that it contains methyl 4-hydroxybenzoate and / or propyl 4-hydroxybenzoate and / or butyl 4-hydroxybenzoate as esters of 4-hydroxybenzoic acid. Veterinary antiviral preparation according to claim 1, 2, characterized in that the preparation is made in the dosage form of a powder, or a sterile solution, or ointment. 4. The veterinary antiviral preparation according to claim 3, characterized in that in the dosage form of a sterile solution it contains piperidinium 2- [5- (furan-2-yl) -4-phenyl-1,2,4-triazol-3-ylthio] acetate , esters of 4-hydroxybenzoic acid and purified water in the following ratios of ingredients, wt.%: Piperidinium 5. The veterinary antiviral preparation according to claim 3, characterized in that in the dosage form of the ointment it contains piperidinium 2- [5- (furan-2-yl) -4-phenyl-1,2,4-triazol-3-ylthio] acetate, esters of 4-hydroxybenzoic acid and lipophilic, or fatty, or hydrophilic ointment base in the following ratios of ingredients, wt.%: Piperidinium |
| priorityDate | 2013-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.